| Financial Year |
March 31 2023 |
| Monetary Funds |
6,630,272,909.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
72,399,133.83 |
| Accounts Receivable |
1,707,227,234.16 |
| Advances to Suppliers |
137,307,338.15 |
| Other Receivables |
688,471,060.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
406,530,580.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,629,159.28 |
| Total Current Assets |
11,595,801,792.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,145,734,694.80 |
| Long-term Equity Investment |
48,454,231,101.32 |
| Investment Properties |
169,365,179.27 |
| Fixed Assetes |
1,093,279,541.24 |
| Under-construction Projects |
1,481,577,592.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,035,763,461.51 |
| R&D expenses |
18,907,153.39 |
| Goodwill |
18,970,982.26 |
| Long-Term Deferred and Prepaid Expenses |
945,157,271.39 |
| Deferred Income Tax Assets |
139,090,945.05 |
| Other Non-Current Assets |
82,499,605.77 |
| Sub-Total of Non-Current Assets |
106,958,824,836.27 |
| Total Assets |
118,554,626,628.74 |
| Short-Term Loans |
1,346,735,849.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
81,787,777.26 |
| Accounts Payable |
1,801,205,707.69 |
| Accounts Received In Advance |
116,084,608.40 |
| Employee Compensation Payable |
316,556,647.32 |
| Taxes Payable |
160,966,358.48 |
| Interest Payable |
-- |
| Dividend Payable |
195,790,019.26 |
| Other payables |
1,493,060,161.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,048,742,420.94 |
| Other Current Liabilities |
1,027,907,388.71 |
| Sub-Total of Current Liabilities |
9,274,560,245.45 |
| Long-term Loans |
21,555,986,464.06 |
| Bonds Payable |
13,558,492,144.91 |
| Long-Term Accounts Payable |
671,985,275.74 |
| Special Payable |
-- |
| Estimatied Liabilities |
63,894,919.96 |
| Deferred Income Tax Liabilities |
3,632,160,952.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,096,368,034.47 |
| Total Liabilities |
49,370,928,279.92 |
| Paid-In Capital(Or Share Stock) |
6,185,183,893.00 |
| Capital Surplus |
28,562,026,954.88 |
| Surplus Reserve |
2,173,517,217.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
19,613,053,957.71 |
| Minority Stockholder's Interest |
7,226,691,550.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
61,957,006,797.95 |
| Owner's Equity（Stockholder's Equity） |
69,183,698,348.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
118,554,626,628.74 |
